SLAB SILICON LABORATORIES INC.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1038074 · Fiscal year ends 01/02
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY21.3%
TTM net income YoY76.4%
TTM EPS YoY77.2%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR—
Margins
Gross margin61.3%
Operating margin-2.6%
Net margin-2.3%
FCF margin0.8%
EBITDA margin0.1%
Returns
ROE-1.9%
ROA-1.6%
ROIC (approx.)-2.5%
Asset turnover0.70x
Leverage & solvency
Liabilities / assets15.8%
Debt / equity0.00x
Current ratio4.60x
Interest coverage-24.97x
Cash quality & payout
Operating cash flow / net income-2.24x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue4.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-03 | 2026Q22026-07-04 | 2026Q12026-04-04 | 2025Q4*2026-01-03 | 2025Q32025-10-04 | 2025Q22025-07-05 | 2025Q12025-04-05 | 2024Q4*2024-12-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $250.89M | $228.19M | $213.50M | $208.21M | $206.00M | $192.84M | $177.71M | $166.25M |
| Cost of revenue | $98.31M | $87.52M | $86.50M | $76.13M | $86.98M | $84.74M | $79.94M | $76.03M |
| Gross profit | $152.58M | $140.67M | $127.00M | $132.08M | $119.02M | $108.11M | $97.78M | $90.22M |
| R&D expense | $93.17M | $95.02M | $88.59M | $89.52M | $87.69M | $87.82M | $88.22M | $82.44M |
| SG&A expense | $51.45M | $56.32M | $55.49M | $45.81M | $43.68M | $43.16M | $41.64M | $36.41M |
| Operating income | $7.95M | -$10.67M | -$17.08M | -$3.25M | -$12.34M | -$22.87M | -$32.08M | -$28.63M |
| Interest expense | $226,000 | $251,000 | $232,000 | $214,000 | $226,000 | $251,000 | $284,000 | $260,000 |
| Pretax income | $10.91M | -$8.43M | -$13.69M | -$534,000 | -$9.52M | -$19.29M | -$28.57M | -$25.91M |
| Income tax | $2.06M | $2.16M | $2.21M | $2.15M | $414,000 | $2.53M | $1.90M | -$2.09M |
| Net income | $8.85M | -$10.59M | -$15.90M | -$2.68M | -$9.94M | -$21.82M | -$30.47M | -$23.82M |
| EBITDA | $13.93M | -$4.54M | -$11.04M | $2.69M | -$6.27M | -$16.41M | -$25.83M | -$22.38M |
| EPS (basic) | 0.27 | -0.32 | -0.48 | — | -0.30 | -0.67 | -0.94 | — |
| EPS (diluted) | 0.26 | -0.32 | -0.48 | — | -0.30 | -0.67 | -0.94 | — |
| Weighted avg. shares (diluted) | 33.75M | 33.21M | 32.96M | — | 32.84M | 32.68M | 32.47M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $423.01M | $362.19M | $383.09M | $364.22M | $341.40M | $314.46M | $324.88M | $281.61M |
| Short-term investments | $16.83M | $35.05M | $55.77M | $79.40M | $97.62M | $101.08M | $99.93M | $100.55M |
| Receivables | $79.97M | $79.80M | $77.12M | $64.51M | $67.31M | $56.50M | $52.07M | $54.48M |
| Inventory | $133.39M | $123.34M | $103.23M | $95.57M | $82.19M | $80.87M | $83.40M | $105.64M |
| Current assets | $724.62M | $671.22M | $676.32M | $674.02M | $652.56M | $617.75M | $618.67M | $602.03M |
| PP&E, net | $131.69M | $130.90M | $131.82M | $128.64M | $128.32M | $131.28M | $129.71M | $132.14M |
| Goodwill | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M |
| Intangibles | $16.25M | $18.54M | $20.84M | $23.13M | $25.43M | $27.72M | $31.06M | $36.50M |
| Total assets | $1.34B | $1.25B | $1.27B | $1.27B | $1.25B | $1.22B | $1.23B | $1.22B |
| Current liabilities | $157.50M | $124.15M | $132.48M | $143.79M | $145.31M | $120.67M | $119.72M | $97.88M |
| Total liabilities | $210.77M | $158.25M | $167.93M | $174.90M | $182.35M | $159.99M | $161.08M | $142.65M |
| Shareholders' equity | $1.13B | $1.09B | $1.10B | $1.09B | $1.07B | $1.06B | $1.07B | $1.08B |
| Shares outstanding | 33.38M | 33.37M | 32.97M | 32.95M | 32.85M | 32.81M | 32.47M | 32.46M |
| Cash flow statement | ||||||||
| Operating cash flow | $46.78M | -$14.51M | $4.93M | $8.35M | $34.32M | $4.91M | $48.13M | $10.13M |
| Capital expenditure | $6.32M | $12.32M | $9.84M | $9.98M | $6.39M | $8.70M | $4.85M | $3.96M |
| Free cash flow | $40.46M | -$26.83M | -$4.90M | -$1.63M | $27.93M | -$3.79M | $43.28M | $6.17M |
| Investing cash flow | $15.30M | $12.35M | $14.89M | $8.78M | -$6.75M | -$10.15M | -$3.90M | -$38.18M |
| Financing cash flow | -$1.26M | -$18.73M | -$956,000 | $5.69M | -$627,000 | -$5.17M | -$958,000 | $6.58M |
| Depreciation & amortization | $5.98M | $6.12M | $6.05M | $5.95M | $6.07M | $6.45M | $6.25M | $6.25M |
| Stock-based compensation | $23.05M | $25.65M | $21.05M | $20.68M | $20.04M | $19.89M | $19.71M | $16.14M |
| Share buybacks | — | — | — | — | — | — | — | $16,000 |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.